Frank M. Ruemmele

18.9k total citations · 4 hit papers
156 papers, 9.9k citations indexed

About

Frank M. Ruemmele is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Frank M. Ruemmele has authored 156 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Genetics, 55 papers in Epidemiology and 46 papers in Surgery. Recurrent topics in Frank M. Ruemmele's work include Inflammatory Bowel Disease (81 papers), Microscopic Colitis (49 papers) and Immunodeficiency and Autoimmune Disorders (25 papers). Frank M. Ruemmele is often cited by papers focused on Inflammatory Bowel Disease (81 papers), Microscopic Colitis (49 papers) and Immunodeficiency and Autoimmune Disorders (25 papers). Frank M. Ruemmele collaborates with scholars based in France, Canada and United Kingdom. Frank M. Ruemmele's co-authors include Olivier Goulet, Dan Turner, Richard K. Russell, Arie Levine, David C. Wilson, Sibylle Koletzko, Jeffrey S. Hyams, Marla Dubinsky, Anne M. Griffiths and Jorge Amil Dias and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Frank M. Ruemmele

150 papers receiving 9.7k citations

Hit Papers

Pediatric modification of the Montreal classification for... 2010 2026 2015 2020 2010 2013 2012 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pediatric modification of the Montreal classification for inflammatory bowel disease
    2010 1.1k citations Arie Levine, Anne M. Griffiths et al. Inflammatory Bowel Diseases profile →
  2. ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
    2013 958 citations Arie Levine, Sibylle Koletzko et al. Journal of Pediatric Gastroenterology and Nutrition profile →
  3. Diagnostic Approach and Management of Cow's‐Milk Protein Allergy in Infants and Children
    2012 528 citations Sibylle Koletzko, B. Niggemann et al. Journal of Pediatric Gastroenterology and Nutrition profile →
  4. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
    2020 454 citations Frank M. Ruemmele et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank M. Ruemmele France 49 5.1k 3.5k 3.3k 2.2k 1.3k 156 9.9k
Arie Levine Israel 41 5.0k 1.0× 2.9k 0.8× 3.5k 1.0× 998 0.4× 583 0.4× 150 7.5k
Antonio Di Sabatino Italy 58 3.3k 0.6× 3.8k 1.1× 3.2k 1.0× 2.9k 1.3× 697 0.5× 320 11.8k
Andrew S. Day New Zealand 51 3.6k 0.7× 3.0k 0.9× 2.6k 0.8× 1.1k 0.5× 1.1k 0.8× 353 8.4k
Torsten Kucharzik Germany 50 3.7k 0.7× 2.5k 0.7× 2.6k 0.8× 2.6k 1.2× 471 0.4× 198 9.2k
Kaija‐Leena Kolho Finland 40 4.0k 0.8× 2.5k 0.7× 3.3k 1.0× 1.2k 0.5× 487 0.4× 204 6.8k
Hans Herfarth United States 55 4.7k 0.9× 3.0k 0.9× 4.2k 1.2× 3.0k 1.3× 510 0.4× 264 12.1k
Alessandro Armuzzi Italy 52 5.8k 1.1× 3.5k 1.0× 4.4k 1.3× 2.1k 0.9× 722 0.6× 435 10.4k
Axel Dignaß Germany 55 10.1k 2.0× 5.1k 1.5× 7.1k 2.1× 2.7k 1.2× 1.2k 0.9× 282 17.3k
Peter M. Irving United Kingdom 52 3.8k 0.7× 2.2k 0.6× 2.4k 0.7× 1.5k 0.7× 532 0.4× 337 9.1k
Richard J. Grand United States 54 4.6k 0.9× 3.3k 0.9× 2.5k 0.7× 905 0.4× 1.5k 1.2× 224 10.1k

Countries citing papers authored by Frank M. Ruemmele

Since Specialization
Citations

This map shows the geographic impact of Frank M. Ruemmele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank M. Ruemmele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank M. Ruemmele more than expected).

Fields of papers citing papers by Frank M. Ruemmele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank M. Ruemmele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank M. Ruemmele. The network helps show where Frank M. Ruemmele may publish in the future.

Co-authorship network of co-authors of Frank M. Ruemmele

This figure shows the co-authorship network connecting the top 25 collaborators of Frank M. Ruemmele. A scholar is included among the top collaborators of Frank M. Ruemmele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank M. Ruemmele. Frank M. Ruemmele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dupont, Claire, D. Caldari, Rémi Duclaux‐Loras, et al.. (2024). Efficacy of infliximab after loss of response of/intolerance to adalimumab in pediatric Crohn's disease: A retrospective multicenter cohort study of the “GETAID pédiatrique”. Journal of Pediatric Gastroenterology and Nutrition. 78(5). 1116–1125. 2 indexed citations
2.
Trinh, Nhung TH, et al.. (2022). Pediatric Prescriptions of Proton Pump Inhibitors in France (2009-2019): A Time-Series Analysis of Trends and Practice Guidelines Impact. The Journal of Pediatrics. 245. 158–164.e4. 21 indexed citations
3.
Bader‐Meunier, Brigitte, Fabienne Charbit‐Henrion, Ulrich Meinzer, et al.. (2021). Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 27(11). 1853–1857. 8 indexed citations
4.
Charbit‐Henrion, Fabienne, Marianna Parlato, Georgia Malamut, Frank M. Ruemmele, & Nadine Cerf–Bensussan. (2021). Intestinal immunoregulation: lessons from human mendelian diseases. Mucosal Immunology. 14(5). 1017–1037. 11 indexed citations
5.
Uhlig, Holm H., Fabienne Charbit‐Henrion, Daniel Kotlarz, et al.. (2020). Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 72(3). 456–473. 79 indexed citations
6.
7.
8.
Neyt, Mattias, Marina Aloi, Lissy de Ridder, et al.. (2020). Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment. JMIR Formative Research. 5(1). e13888–e13888. 1 indexed citations
9.
Hyams, Jeffrey S., Marla C. Dubinsky, Joel R. Rosh, et al.. (2018). The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn’s disease: a post hoc analysis. Alimentary Pharmacology & Therapeutics. 49(2). 155–164. 21 indexed citations
10.
Navas‐López, Víctor Manuel, Javier Martín‐de‐Carpi, Amy Grant, et al.. (2016). P113. Quality of life in paediatric Crohn’s disease: data from the Imagekids study. Journal of Crohn s and Colitis. 10(suppl 1). S145–S146. 1 indexed citations
11.
Dupont, Claire, A. Dabadie, Corinne Alberti, & Frank M. Ruemmele. (2014). Predictors of response to infliximab in paediatric perianal Crohn's disease. Alimentary Pharmacology & Therapeutics. 40(8). 917–929. 28 indexed citations
12.
Koletzko, Sibylle, B. Niggemann, András Arató, et al.. (2012). Diagnostic Approach and Management of Cow's‐Milk Protein Allergy in Infants and Children. Journal of Pediatric Gastroenterology and Nutrition. 55(2). 221–229. 528 indexed citations breakdown →
13.
Garnier‐Lengliné, Hélène, Nicole Brousse, Sophie Candon, et al.. (2012). Have serological tests changed the face of childhood coeliac disease? A retrospective cohort study. BMJ Open. 2(6). e001385–e001385. 7 indexed citations
14.
Pigneur, Bénédicte, Hélène Garnier‐Lengliné, Cécile Talbotec, et al.. (2011). The efficacy of exclusive nutritional therapy in paediatric Crohn’s disease, comparing fractionated oral vs. continuous enteral feeding. Alimentary Pharmacology & Therapeutics. 33(12). 1332–1339. 121 indexed citations
15.
Levine, Arie, Anne M. Griffiths, James Markowitz, et al.. (2010). Pediatric modification of the Montreal classification for inflammatory bowel disease. Inflammatory Bowel Diseases. 17(6). 1314–1321. 1054 indexed citations breakdown →
16.
Ruemmele, Frank M.. (2009). Immunomodulation with Methotrexate: Underused and Undervalued?. Digestive Diseases. 27(3). 312–314. 2 indexed citations
17.
Ruemmele, Frank M., Sylvie Fraïtag, Frédéric Rieux‐Laucat, et al.. (2008). Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. British Journal of Dermatology. 160(3). 645–651. 85 indexed citations
18.
Torgerson, Troy R., Nicolette Moes, Stephanie Anover, et al.. (2007). Severe Food Allergy as a Variant of IPEX Syndrome Caused by a Deletion in a Noncoding Region of the FOXP3 Gene. Gastroenterology. 132(5). 1705–1717. 192 indexed citations
19.
Uhlen, S, Reda Belbouab, Olivier Goulet, et al.. (2006). EFFICACY OF METHOTREXATE IN THE TREATMENT OF PAEDIATRIC CROHN'S DISEASE. Journal of Pediatric Gastroenterology and Nutrition. 42(5). 1 indexed citations
20.
Martinez‐Vinson, Christine, Olivier Goulet, D. Berrebi, et al.. (2005). SYNDROMATIC DIARRHEA IN CHILDREN. REPORT OF 8 CASES. Journal of Pediatric Gastroenterology and Nutrition. 40(5). 651–652. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arie Levine Breakdown of academic impact, for papers by Antonio Di Sabatino Breakdown of academic impact, for papers by Andrew S. Day Breakdown of academic impact, for papers by Torsten Kucharzik Breakdown of academic impact, for papers by Kaija‐Leena Kolho Breakdown of academic impact, for papers by Hans Herfarth Breakdown of academic impact, for papers by Alessandro Armuzzi Breakdown of academic impact, for papers by Axel Dignaß Breakdown of academic impact, for papers by Peter M. Irving Breakdown of academic impact, for papers by Richard J. Grand
Rankless by CCL
2026